Beijing Wantai Biological Pharmacy Enterprise Co. Ltd Financials

Market Capitalization CN¥58.07 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	826.25
Forward PE	78.84
Price to Sales TTM	CN¥31.64
Price to Book MRQ	CN¥4.70
Enterprise to Revenue	29.12
Enterprise to EBITDA	-120.89

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	-18.59%
Operating Margin	-0.31%
Return on Assets TTM	-3.05%
Return on Equity TTM	-2.70%

Income Statement

Revenue TTM	CN¥1,795,661,824
Revenue per Share TTM	CN¥1.38
Quarterly Revenue Growth	12.50%
Gross Profit TTM	CN¥858,532,352
EBITDA	CN¥452,623,395
Net Income to Common TTM	CN¥-333,835,616
Diluted EPS TTM	CN¥-0.27
Quarterly Earnings Growth YoY	-27.81%

Balance Sheet

Total Cash MRQ	CN¥5,128,184,320
Total Cash per Share MRQ	CN¥4.05
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	3.04
Current Ratio MRQ	4.27
Book Value per Share MRQ	CN¥9.56

Cash Flow

Operating Cash Flow TTM	CN¥164,570,944
Levered Free Cash Flow TTM	CN¥-405,595,392

603392 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	1,265,122,774
Float Shares	257,148,855
Avg 10 Volume	2,535,543
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	80.87%
% Held by Institutions	3.23%

Stock Price Summary

Beta	1.39
Fifty Two Week Low	CN¥44.79
Fifty Two Week High	CN¥80.00
Fifty Two Week Change	-55.07%
Day 50 MA	CN¥50.68
Day 200 MA	CN¥59.02

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.28
Forward Annual Dividend Yield	2.85%
Trailing Annual Dividend Rate	CN¥0.32
Trailing Annual Dividend Yield	0.71%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date	2024-06-03
Last Split Factor
Last Split Date	2023-06-05